The company, in which the late Rakesh Jhunjhunwala is also a promoter, simultaneously witnessed a stake reduction of 1,255 basis points to 1.55% in the October to December quarter from 14.10% in Q2FY26.
Jhunjhunwala’s additional stake buy in the company comes amid continuous underperformance in the stock. The stock has slipped nearly 6% in the past 12 months, in line with the sector’s poor show. The Nifty Pharma index has fallen 3% during this period compared with the Nifty’s 8% growth.
Star Health is a Chennai-headquartered company providing health insurance services. The company claims to have a network of 14,000 hospitals and over 850 branch offices spread across the country.
Shares of Star Health are currently trading below their 50-day and 200-day simple moving averages (SMAs) of Rs 470 and Rs 445, respectively, according to Trendlyne data.
Its standalone net profit in the September-ended quarter fell 51% to Rs 55 crore versus Rs 111 crore in the year-ago period. Total revenue stood at Rs 4,381 crore, up 8% compared with Rs 4,061 crore in the corresponding quarter of the last financial year.As per the latest corporate shareholdings compiled by Trendlyne, Rekha Jhunjhunwala publicly holds 26 stocks with a net worth of over Rs 44,238 crore.Her stake is valued at Rs 4,000 crore in Star Health, the data said.
Some of the other stocks in her portfolio include Aptech, Sundrop Brands, Valor Estate, Escorts Kubota, Federal Bank and Fortis Healthcare.
Also Read: Vijay Kedia adds smallcap power stock to portfolio in December quarter. Check details
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)
-1024x683.jpg "Trump, Congress, and the FISA Fiasco")
-1024x683.jpg "Strait Outta Hormuz: Getting the Iran Oil Story Straight")
